News

Published on 10 Feb 2024 on GuruFocus.com via Yahoo Finance

PRIMECAP Management's Strategic Exits and New Positions Highlight Q4 Moves


Article preview image

Seagen Inc. Sale Marks Notable Portfolio Change for PRIMECAP Management (Trades, Portfolio)

PRIMECAP Management (Trades, Portfolio), an esteemed investment firm known for its value-driven approach and long-term investment horizon, has revealed its 13F filings for the fourth quarter of 2023. Founded in 1983 and based in Pasadena, CA, PRIMECAP specializes in managing US equity portfolios for institutions and mutual funds. The firm's investment philosophy is anchored in four key principles: individual decision-making, rigorous fundamental research, a long-term perspective, and a keen focus on value. PRIMECAP's multi-counselor model allows each portfolio manager to independently manage a segment of the fund, fostering a diverse range of investment strategies under one roof. The firm is adept at identifying undervalued stocks, particularly in sectors that are currently out of favor, and patiently waits for the market to align with its valuation assessments.

PRIMECAP Management's Strategic Exits and New Positions Highlight Q4 MovesPRIMECAP Management's Strategic Exits and New Positions Highlight Q4 Moves

NYSE.IT price evolution
NYSE.NVS price evolution
SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Novartis AG (NVS): Among the Cheap Healthcare Stocks to Buy Heading Into 2025

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this...

Insider Monkey · via Yahoo Finance 28 Dec 2024

Peninsula drugmaker lands $150 million, food allergy drug to fill pipeline hole...

The South San Francisco company (Nasdaq: RAPT) also said it lined up $150 million from a...

The Business Journals 23 Dec 2024

Why Is Novartis AG (NVS) Among the Best European Dividend Stocks To Buy Now?

We recently compiled a list of the 10 Best European Dividend Stocks To Buy. In this article, we a...

Insider Monkey · via Yahoo Finance 23 Dec 2024

Is iShares International Equity Factor ETF (INTF) a Strong ETF Right Now?

And, most ETFs are very transparent products that disclose their holdings on a daily basis....

Zacks · via Yahoo Finance 23 Dec 2024

Buy 5 Large-Cap Laggards of 2024 Likely to Surge in the Near Term

Year to date, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — hav...

Zacks 23 Dec 2024

European Health Stocks Brace for Year Clouded by US Politics

(Bloomberg) -- After falling off their perch in the last few months of 2024, European healthcare...

Bloomberg · via Yahoo Finance 19 Dec 2024

Novartis AG (NVS): Among the Oversold Global Stocks to Buy Right Now

We recently compiled a list of the 10 Oversold Global Stocks To Buy Right Now. In this article, w...

Insider Monkey · via Yahoo Finance 18 Dec 2024

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

Voyager Therapeutics, Inc. price-consensus-chart | Voyager Therapeutics, Inc. Quote VYGR also...

Zacks · via Yahoo Finance 18 Dec 2024

Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report

The Institute for Clinical and Economic Review (ICER) has identified five prescription drugs whos...

Benzinga · via Yahoo Finance 13 Dec 2024

The Zacks Analyst Blog Mastercard, The Procter & Gamble, Novartis AG, IDT and...

These research reports have been hand-picked from roughly 70 reports published by our analyst tea...

Zacks · via Yahoo Finance 13 Dec 2024